title: Allergic rhinitis is an extremely common problem, but prevalence rates widely vary between countries.
authors.affiliation: Professor of Paediatrics, Imperial College London, London, UK.
authors.forename: J O
authors.initials: JO
authors.lastname: Warner
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers / Q000097:blood / Q000652:urine; D017326:Clinical Trials, Phase III as Topic; D015897:Comorbidity; D003888:Desensitization, Immunologic; D003937:Diagnosis, Differential; D003955:Diagnostic Tests, Routine / Q000592:standards; D006801:Humans; D020738:Leptin / Q000097:blood; D009569:Nitric Oxide / Q000031:analogs & derivatives / Q000652:urine; D000069444:Omalizumab; D011358:Product Surveillance, Postmarketing; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis* / Q000453:epidemiology* / Q000503:physiopathology / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis* / Q000453:epidemiology* / Q000503:physiopathology / Q000628:therapy; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D020738:Leptin; D000069444:Omalizumab; D009569:Nitric Oxide